SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5i1w'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DZ6_B_CAMB502_0 (CYTOCHROME P450-CAM)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	4 / 5	PHE A 34 TYR A 16 VAL A 28 VAL A 75	None	1.46A	1dz6B-5i1wA: undetectable	1dz6B-5i1wA: 20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GEB_A_CAMA418_0 (CYTOCHROME P450-CAM)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	5 / 9	PHE A 34 TYR A 16 VAL A 28 VAL A 75 ILE A 78	None	1.40A	1gebA-5i1wA: undetectable	1gebA-5i1wA: 21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JTV_A_TESA500_1 (17 BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	4 / 8	VAL A 59 TYR A 200 HIS A 186 SER A 134	FAD A 601 (-4.5A) None None None	1.01A	1jtvA-5i1wA: undetectable	1jtvA-5i1wA: 22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RV7_B_AB1B1001_1 (PROTEASE)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	5 / 11	ASN A 460 ILE A 447 PRO A 438 VAL A 435 ALA A 494	None	1.20A	1rv7A-5i1wA: undetectable 1rv7B-5i1wA: undetectable	1rv7A-5i1wA: 11.18 1rv7B-5i1wA: 11.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TMX_B_BEZB882_0 (HYDROXYQUINOL 1,2-DIOXYGENASE)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	5 / 12	LEU A 267 GLY A 139 PRO A 140 TYR A 108 HIS A 132	None FAD A 601 ( 4.9A) None None FAD A 601 (-4.2A)	1.26A	1tmxB-5i1wA: undetectable	1tmxB-5i1wA: 21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AVD_B_SAMB601_0 (CATECHOL-O-METHYLTRA NSFERASE)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	5 / 12	GLY A 444 VAL A 435 ASP A 346 ALA A 445 TYR A 470	None	1.33A	2avdB-5i1wA: undetectable	2avdB-5i1wA: 19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JN3_A_JN3A131_1 (FATTY ACID-BINDING PROTEIN, LIVER)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	5 / 12	ILE A 378 THR A 402 LEU A 400 LEU A 326 PHE A 247	None	1.20A	2jn3A-5i1wA: undetectable	2jn3A-5i1wA: 12.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OUZ_A_C3DA999_1 (ESTROGEN RECEPTOR)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	4 / 6	ALA A 211 ASP A 210 GLU A 214 ARG A 218	None	1.18A	2ouzA-5i1wA: undetectable	2ouzA-5i1wA: 17.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OXT_A_SAMA300_0 (NUCLEOSIDE-2'-O-METH YLTRANSFERASE)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	5 / 12	GLY A 122 GLY A 130 GLY A 128 LEU A 81 ILE A 197	FAD A 601 (-3.2A) FAD A 601 (-3.6A) FAD A 601 (-3.7A) FAD A 601 (-4.7A) FAD A 601 (-3.6A)	1.06A	2oxtA-5i1wA: undetectable	2oxtA-5i1wA: 20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QBO_A_CAMA442_0 (CYTOCHROME P450-CAM)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	5 / 10	PHE A 34 TYR A 16 VAL A 28 VAL A 75 ILE A 78	None	1.45A	2qboA-5i1wA: undetectable	2qboA-5i1wA: 22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2R5P_B_MK1B902_2 (PROTEASE)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	6 / 12	GLY A 128 ALA A 129 ILE A 197 GLY A 191 VAL A 149 ILE A 133	FAD A 601 (-3.7A) None FAD A 601 (-3.6A) FAD A 601 (-3.3A) None None	1.37A	2r5pB-5i1wA: undetectable	2r5pB-5i1wA: 10.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VOU_B_ACTB1391_0 (2,6-DIHYDROXYPYRIDIN E HYDROXYLASE)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	3 / 3	PRO A 120 GLY A 146 TYR A 151	None	0.71A	2vouB-5i1wA: undetectable	2vouB-5i1wA: 23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VOU_C_ACTC1391_0 (2,6-DIHYDROXYPYRIDIN E HYDROXYLASE)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	3 / 3	PRO A 120 GLY A 146 TYR A 151	None	0.70A	2vouC-5i1wA: undetectable	2vouC-5i1wA: 23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BOG_D_DHID8_0 (6.5 KDA GLYCINE-RICH ANTIFREEZE PROTEIN)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	4 / 4	SER A 142 GLY A 146 GLY A 121 GLY A 137	None None None FAD A 601 (-3.6A)	0.80A	3bogB-5i1wA: undetectable 3bogD-5i1wA: undetectable	3bogB-5i1wA: undetectable 3bogD-5i1wA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EM4_A_DR7A100_1 (PROTEASE)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	6 / 11	GLY A 128 ALA A 129 ILE A 197 GLY A 191 VAL A 149 ILE A 133	FAD A 601 (-3.7A) None FAD A 601 (-3.6A) FAD A 601 (-3.3A) None None	1.40A	3em4A-5i1wA: undetectable	3em4A-5i1wA: 10.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JAY_A_SAMA1102_0 (STRUCTURAL PROTEIN VP3)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	5 / 12	ILE A 447 GLY A 190 GLY A 189 ALA A 185 ILE A 497	None	1.00A	3jayA-5i1wA: undetectable	3jayA-5i1wA: 19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OWX_B_XRAB233_1 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	5 / 11	VAL A 79 GLY A 130 GLY A 131 ASN A 448 ILE A 197	None FAD A 601 (-3.6A) FAD A 601 (-3.2A) FAD A 601 ( 3.5A) FAD A 601 (-3.6A)	1.32A	3owxA-5i1wA: undetectable 3owxB-5i1wA: undetectable	3owxA-5i1wA: 18.20 3owxB-5i1wA: 18.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TKA_A_SAMA400_0 (RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE H)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	5 / 12	GLY A 349 ARG A 348 HIS A 351 ARG A 253 SER A 399	None	1.28A	3tkaA-5i1wA: undetectable	3tkaA-5i1wA: 21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FGL_A_CLQA303_0 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	5 / 12	GLY A 130 GLY A 131 ASN A 448 ILE A 197 VAL A 79	FAD A 601 (-3.6A) FAD A 601 (-3.2A) FAD A 601 ( 3.5A) FAD A 601 (-3.6A) None	1.21A	4fglA-5i1wA: undetectable 4fglB-5i1wA: undetectable	4fglA-5i1wA: 17.80 4fglB-5i1wA: 17.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L1A_A_AB1A101_1 (MDR769 HIV-1 PROTEASE)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	5 / 11	ASN A 460 ASP A 451 PRO A 438 THR A 437 VAL A 435	None	1.14A	4l1aA-5i1wA: undetectable	4l1aA-5i1wA: 11.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TVT_A_ASCA302_0 (THAUMATIN-1)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	3 / 3	ARG A 35 GLN A 42 GLU A 45	None	0.76A	4tvtA-5i1wA: undetectable	4tvtA-5i1wA: 18.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YOA_A_017A100_1 (HIV-1 PROTEASE)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	4 / 6	ASN A 460 PRO A 438 THR A 437 VAL A 435	None	0.92A	4yoaA-5i1wA: undetectable	4yoaA-5i1wA: 10.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B2S_A_ACTA107_0 (CRISPR-ASSOCIATED ENDONUCLEASE CAS9 GUIDE RNA)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	3 / 3	VAL A 170 THR A 172 ARG A 93	None	0.65A	5b2sB-5i1wA: undetectable	5b2sB-5i1wA: 15.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B2T_A_ACTA108_0 (CRISPR-ASSOCIATED ENDONUCLEASE CAS9 GUIDE RNA)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	3 / 3	VAL A 170 THR A 172 ARG A 93	None	0.62A	5b2tB-5i1wA: undetectable	5b2tB-5i1wA: 15.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DV4_A_NMYA601_2 (CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 6-LIKE)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	3 / 3	GLU A 301 TRP A 297 ASN A 254	None	1.00A	5dv4A-5i1wA: undetectable	5dv4A-5i1wA: 20.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ERG_B_SAMB401_0 (TRNA (ADENINE(58)-N(1))-M ETHYLTRANSFERASE CATALYTIC SUBUNIT TRM61)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	5 / 12	ILE A 197 VAL A 196 GLY A 191 PHE A 491 HIS A 64	FAD A 601 (-3.6A) FAD A 601 ( 4.1A) FAD A 601 (-3.3A) None FAD A 601 ( 2.7A)	1.09A	5ergB-5i1wA: undetectable	5ergB-5i1wA: 21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KOX_A_RFPA502_1 (PENTACHLOROPHENOL 4-MONOOXYGENASE)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	5 / 12	GLY A 66 GLY A 332 ILE A 336 GLY A 62 GLY A 63	67L A 602 (-3.5A) None None FAD A 601 (-3.2A) FAD A 601 (-3.5A)	0.88A	5koxA-5i1wA: undetectable	5koxA-5i1wA: 24.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KXI_D_NCTD402_1 (NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-4 NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT BETA-2)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	4 / 8	TYR A 112 TRP A 319 THR A 322 LEU A 141	None	1.46A	5kxiD-5i1wA: undetectable 5kxiE-5i1wA: undetectable	5kxiD-5i1wA: 20.23 5kxiE-5i1wA: 20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	4 / 5	LEU A 347 LEU A 400 MET A 375 GLN A 355	None	1.35A	5uc3A-5i1wA: undetectable	5uc3A-5i1wA: 9.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WM2_A_ACTA605_0 (SALICYLATE-AMP LIGASE)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	3 / 3	THR A 40 THR A 198 ARG A 199	None	1.05A	5wm2A-5i1wA: undetectable	5wm2A-5i1wA: 21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BRD_C_RFPC502_1 (RIFAMPIN MONOOXYGENASE)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	5 / 12	VAL A 70 GLY A 126 VAL A 104 PHE A 119 GLY A 135	FAD A 601 (-4.5A) None None None None	1.19A	6brdC-5i1wA: undetectable	6brdC-5i1wA: 11.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CNJ_D_NCTD402_1 (NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-4 NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT BETA-2)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	4 / 8	TYR A 112 TRP A 319 THR A 322 LEU A 141	None	1.46A	6cnjD-5i1wA: undetectable 6cnjE-5i1wA: undetectable	6cnjD-5i1wA: 12.38 6cnjE-5i1wA: 10.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HU9_S_PCFS603_0 (CYTOCHROME B-C1 COMPLEX SUBUNIT 8 CYTOCHROME C OXIDASE POLYPEPTIDE 5A, MITOCHONDRIAL)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	4 / 7	GLY A 192 PHE A 194 VAL A 159 SER A 134	FAD A 601 (-3.8A) None None None	0.98A	6hu9S-5i1wA: undetectable 6hu9q-5i1wA: undetectable	6hu9S-5i1wA: 10.55 6hu9q-5i1wA: 14.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MN4_A_AM2A301_0 (AMINOGLYCOSIDE N(3)-ACETYLTRANSFERA SE, AAC(3)-IVA)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	4 / 8	HIS A 362 ARG A 419 GLU A 423 GLU A 416	None	1.21A	6mn4A-5i1wA: undetectable	6mn4A-5i1wA: 21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MN4_B_AM2B301_0 (AMINOGLYCOSIDE N(3)-ACETYLTRANSFERA SE, AAC(3)-IVA)	5i1w	CRMK (Actinoalloteichu s sp. WH1-2216-6)	4 / 8	HIS A 362 ARG A 419 GLU A 423 GLU A 416	None	1.21A	6mn4B-5i1wA: undetectable	6mn4B-5i1wA: 21.00

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1DZ6_B_CAMB502_0","CYTOCHROME P450-CAM","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",4,"PHE A  34;TYR A  16;VAL A  28;VAL A  75","None","1.46A","1dz6B-5i1wA:undetectable","1dz6B-5i1wA:20.89"],["1GEB_A_CAMA418_0","CYTOCHROME P450-CAM","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",5,"PHE A  34;TYR A  16;VAL A  28;VAL A  75;ILE A  78","None","1.40A","1gebA-5i1wA:undetectable","1gebA-5i1wA:21.24"],["1JTV_A_TESA500_1","17 BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",4,"VAL A  59;TYR A 200;HIS A 186;SER A 134","FAD A 601 (-4.5A);None;None;None","1.01A","1jtvA-5i1wA:undetectable","1jtvA-5i1wA:22.76"],["1RV7_B_AB1B1001_1","PROTEASE;PROTEASE","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",5,"ASN A 460;ILE A 447;PRO A 438;VAL A 435;ALA A 494","None","1.20A","1rv7A-5i1wA:undetectable;1rv7B-5i1wA:undetectable","1rv7A-5i1wA:11.18;1rv7B-5i1wA:11.18"],["1TMX_B_BEZB882_0","HYDROXYQUINOL 1,2-DIOXYGENASE","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",5,"LEU A 267;GLY A 139;PRO A 140;TYR A 108;HIS A 132","None;FAD A 601 ( 4.9A);None;None;FAD A 601 (-4.2A)","1.26A","1tmxB-5i1wA:undetectable","1tmxB-5i1wA:21.83"],["2AVD_B_SAMB601_0","CATECHOL-O-METHYLTRANSFERASE","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",5,"GLY A 444;VAL A 435;ASP A 346;ALA A 445;TYR A 470","None","1.33A","2avdB-5i1wA:undetectable","2avdB-5i1wA:19.80"],["2JN3_A_JN3A131_1","FATTY ACID-BINDING PROTEIN, LIVER","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",5,"ILE A 378;THR A 402;LEU A 400;LEU A 326;PHE A 247","None","1.20A","2jn3A-5i1wA:undetectable","2jn3A-5i1wA:12.32"],["2OUZ_A_C3DA999_1","ESTROGEN RECEPTOR","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",4,"ALA A 211;ASP A 210;GLU A 214;ARG A 218","None","1.18A","2ouzA-5i1wA:undetectable","2ouzA-5i1wA:17.60"],["2OXT_A_SAMA300_0","NUCLEOSIDE-2'-O-METHYLTRANSFERASE","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",5,"GLY A 122;GLY A 130;GLY A 128;LEU A  81;ILE A 197","FAD A 601 (-3.2A);FAD A 601 (-3.6A);FAD A 601 (-3.7A);FAD A 601 (-4.7A);FAD A 601 (-3.6A)","1.06A","2oxtA-5i1wA:undetectable","2oxtA-5i1wA:20.75"],["2QBO_A_CAMA442_0","CYTOCHROME P450-CAM","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",5,"PHE A  34;TYR A  16;VAL A  28;VAL A  75;ILE A  78","None","1.45A","2qboA-5i1wA:undetectable","2qboA-5i1wA:22.74"],["2R5P_B_MK1B902_2","PROTEASE","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",6,"GLY A 128;ALA A 129;ILE A 197;GLY A 191;VAL A 149;ILE A 133","FAD A 601 (-3.7A);None;FAD A 601 (-3.6A);FAD A 601 (-3.3A);None;None","1.37A","2r5pB-5i1wA:undetectable","2r5pB-5i1wA:10.78"],["2VOU_B_ACTB1391_0","2,6-DIHYDROXYPYRIDINE HYDROXYLASE","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",3,"PRO A 120;GLY A 146;TYR A 151","None","0.71A","2vouB-5i1wA:undetectable","2vouB-5i1wA:23.64"],["2VOU_C_ACTC1391_0","2,6-DIHYDROXYPYRIDINE HYDROXYLASE","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",3,"PRO A 120;GLY A 146;TYR A 151","None","0.70A","2vouC-5i1wA:undetectable","2vouC-5i1wA:23.64"],["3BOG_D_DHID8_0","6.5 KDA GLYCINE-RICH ANTIFREEZE PROTEIN","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",4,"SER A 142;GLY A 146;GLY A 121;GLY A 137","None;None;None;FAD A 601 (-3.6A)","0.80A","3bogB-5i1wA:undetectable;3bogD-5i1wA:undetectable","3bogB-5i1wA:undetectable;3bogD-5i1wA:undetectable"],["3EM4_A_DR7A100_1","PROTEASE","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",6,"GLY A 128;ALA A 129;ILE A 197;GLY A 191;VAL A 149;ILE A 133","FAD A 601 (-3.7A);None;FAD A 601 (-3.6A);FAD A 601 (-3.3A);None;None","1.40A","3em4A-5i1wA:undetectable","3em4A-5i1wA:10.61"],["3JAY_A_SAMA1102_0","STRUCTURAL PROTEIN VP3","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",5,"ILE A 447;GLY A 190;GLY A 189;ALA A 185;ILE A 497","None","1.00A","3jayA-5i1wA:undetectable","3jayA-5i1wA:19.05"],["3OWX_B_XRAB233_1","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE];RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",5,"VAL A  79;GLY A 130;GLY A 131;ASN A 448;ILE A 197","None;FAD A 601 (-3.6A);FAD A 601 (-3.2A);FAD A 601 ( 3.5A);FAD A 601 (-3.6A)","1.32A","3owxA-5i1wA:undetectable;3owxB-5i1wA:undetectable","3owxA-5i1wA:18.20;3owxB-5i1wA:18.20"],["3TKA_A_SAMA400_0","RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE H","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",5,"GLY A 349;ARG A 348;HIS A 351;ARG A 253;SER A 399","None","1.28A","3tkaA-5i1wA:undetectable","3tkaA-5i1wA:21.34"],["4FGL_A_CLQA303_0","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",5,"GLY A 130;GLY A 131;ASN A 448;ILE A 197;VAL A  79","FAD A 601 (-3.6A);FAD A 601 (-3.2A);FAD A 601 ( 3.5A);FAD A 601 (-3.6A);None","1.21A","4fglA-5i1wA:undetectable;4fglB-5i1wA:undetectable","4fglA-5i1wA:17.80;4fglB-5i1wA:17.80"],["4L1A_A_AB1A101_1","MDR769 HIV-1 PROTEASE","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",5,"ASN A 460;ASP A 451;PRO A 438;THR A 437;VAL A 435","None","1.14A","4l1aA-5i1wA:undetectable","4l1aA-5i1wA:11.18"],["4TVT_A_ASCA302_0","THAUMATIN-1","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",3,"ARG A  35;GLN A  42;GLU A  45","None","0.76A","4tvtA-5i1wA:undetectable","4tvtA-5i1wA:18.59"],["4YOA_A_017A100_1","HIV-1 PROTEASE","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",4,"ASN A 460;PRO A 438;THR A 437;VAL A 435","None","0.92A","4yoaA-5i1wA:undetectable","4yoaA-5i1wA:10.20"],["5B2S_A_ACTA107_0","CRISPR-ASSOCIATED ENDONUCLEASE CAS9;GUIDE RNA","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",3,"VAL A 170;THR A 172;ARG A  93","None","0.65A","5b2sB-5i1wA:undetectable","5b2sB-5i1wA:15.33"],["5B2T_A_ACTA108_0","CRISPR-ASSOCIATED ENDONUCLEASE CAS9;GUIDE RNA","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",3,"VAL A 170;THR A 172;ARG A  93","None","0.62A","5b2tB-5i1wA:undetectable","5b2tB-5i1wA:15.33"],["5DV4_A_NMYA601_2","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 6-LIKE","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",3,"GLU A 301;TRP A 297;ASN A 254","None","1.00A","5dv4A-5i1wA:undetectable","5dv4A-5i1wA:20.54"],["5ERG_B_SAMB401_0","TRNA (ADENINE(58)-N(1))-METHYLTRANSFERASE CATALYTIC SUBUNIT TRM61","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",5,"ILE A 197;VAL A 196;GLY A 191;PHE A 491;HIS A  64","FAD A 601 (-3.6A);FAD A 601 ( 4.1A);FAD A 601 (-3.3A);None;FAD A 601 ( 2.7A)","1.09A","5ergB-5i1wA:undetectable","5ergB-5i1wA:21.03"],["5KOX_A_RFPA502_1","PENTACHLOROPHENOL 4-MONOOXYGENASE","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",5,"GLY A  66;GLY A 332;ILE A 336;GLY A  62;GLY A  63","67L A 602 (-3.5A);None;None;FAD A 601 (-3.2A);FAD A 601 (-3.5A)","0.88A","5koxA-5i1wA:undetectable","5koxA-5i1wA:24.38"],["5KXI_D_NCTD402_1","NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-4;NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT BETA-2","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",4,"TYR A 112;TRP A 319;THR A 322;LEU A 141","None","1.46A","5kxiD-5i1wA:undetectable;5kxiE-5i1wA:undetectable","5kxiD-5i1wA:20.23;5kxiE-5i1wA:20.04"],["5UC3_A_486A801_2","GLUCOCORTICOID RECEPTOR","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",4,"LEU A 347;LEU A 400;MET A 375;GLN A 355","None","1.35A","5uc3A-5i1wA:undetectable","5uc3A-5i1wA:9.90"],["5WM2_A_ACTA605_0","SALICYLATE-AMP LIGASE","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",3,"THR A  40;THR A 198;ARG A 199","None","1.05A","5wm2A-5i1wA:undetectable","5wm2A-5i1wA:21.67"],["6BRD_C_RFPC502_1","RIFAMPIN MONOOXYGENASE","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",5,"VAL A  70;GLY A 126;VAL A 104;PHE A 119;GLY A 135","FAD A 601 (-4.5A);None;None;None;None","1.19A","6brdC-5i1wA:undetectable","6brdC-5i1wA:11.06"],["6CNJ_D_NCTD402_1","NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-4;NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT BETA-2","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",4,"TYR A 112;TRP A 319;THR A 322;LEU A 141","None","1.46A","6cnjD-5i1wA:undetectable;6cnjE-5i1wA:undetectable","6cnjD-5i1wA:12.38;6cnjE-5i1wA:10.00"],["6HU9_S_PCFS603_0","CYTOCHROME B-C1 COMPLEX SUBUNIT 8;CYTOCHROME C OXIDASE POLYPEPTIDE 5A, MITOCHONDRIAL","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",4,"GLY A 192;PHE A 194;VAL A 159;SER A 134","FAD A 601 (-3.8A);None;None;None","0.98A","6hu9S-5i1wA:undetectable;6hu9q-5i1wA:undetectable","6hu9S-5i1wA:10.55;6hu9q-5i1wA:14.17"],["6MN4_A_AM2A301_0","AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE, AAC(3)-IVA","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",4,"HIS A 362;ARG A 419;GLU A 423;GLU A 416","None","1.21A","6mn4A-5i1wA:undetectable","6mn4A-5i1wA:21.00"],["6MN4_B_AM2B301_0","AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE, AAC(3)-IVA","5i1w","CRMK","Actinoalloteichus sp. WH1-2216-6",4,"HIS A 362;ARG A 419;GLU A 423;GLU A 416","None","1.21A","6mn4B-5i1wA:undetectable","6mn4B-5i1wA:21.00"]]